Jan 11, 2024 / 06:30PM GMT
Dan Delfico J.P. Morgan Securities LLC-Analyst
Good morning, everybody. Welcome to the 42nd Annual J.P. Morgan Healthcare Conference. My name is Dan Delfico. I'm one of the associates on the healthcare banking team here. This morning, it's my pleasure to introduce you to the Absci team. With us today, we have Sean McClain, Founder and CEO.
(Conference Instructions)
So with that, I'm going to turn it over to Sean.
Sean McClain - Absci Corp - Chief Executive Officer, Founder, Director
Great. Thank you, Dan and J.P. Morgan, for hosting us here. As Dan said, I'm Sean McClain, the Founder and CEO of Absci. We're a data-first generative AI drug creation company. And you may recall from last J.P. Morgan, we announced some really exciting breakthroughs in generative AI for biologic design.
Being able to design an antibody from scratch with a generative AI model, being able to feed in a target of interest, and then being able to have a binder to that target.
Now, that was a big technical feat from an AI perspective. And we
Absci Corp at JPMorgan Healthcare Conference Transcript
Jan 12, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers